Molnupiravir is an orally active antiviral prodrug classified as a cytidine analog that functions by inducing RNA polymerase errors to inhibit the replication of RNA viruses such as COVID-19. This category… Read more
Molnupiravir is an orally active antiviral prodrug classified as a cytidine analog that functions by inducing RNA polymerase errors to inhibit the replication of RNA viruses such as COVID-19. This category provides a comprehensive range of Molnupiravir reference standards, including the active pharmaceutical ingredient, synthetic intermediates, and various related compounds. Pharmaceutical laboratories utilize these materials for rigorous impurity profiling, ensuring that process-related impurities, synthetic byproducts, and potential degradation products are identified and quantified during quality control. Stable isotope labelled Molnupiravir compounds are essential tools for mass spectrometry-based analytical testing, allowing for precise quantification and method validation across complex matrices. By incorporating these pharmacopeial and non-pharmacopeial standards, researchers and quality control departments can maintain regulatory compliance and verify the quality and safety of the drug substance throughout the manufacturing and formulation processes.